RadioMedix Appoints Brian A. Markison to Board of Directors
Leading pharmaceutical executive brings over 4 decades of commercial, M&A, and governance leadershipHOUSTON, July 15, 2026 (GLOBE NEWSWIRE) -- RadioMedix,...
Neuroscience
Riyadh Gets Its First Luxury Brain Wellness Assessment as Brainify.AI Launches with The Longevity Suite
Brainify.AI's new longevity platform brings measurable cognitive wellness to The Longevity Suite's Riyadh clinic, marking its debut in the luxury...
Former Client and Three-Decade Data Sciences Leader John Reynders, PhD, Joins Rancho BioSciences Leadership on Board of Directors
This appointment reflects the company's continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience...
Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth
Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise TransformationALHAMBRA, Calif., July 13, 2026...
Retia Medical Appoints Christopher Benassi to Strategic Advisory Board
Veteran Baxter Connected Care Executive Christopher Benassi Joins Advisory Board as Company Advances FDA-Cleared Cardiovascular Intelligence PlatformWHITE PLAINS, N.Y., July...
Retia Medical Appoints Christopher Benassi to Strategic Advisory Board
Veteran Baxter Connected Care Executive Christopher Benassi Joins Advisory Board as Company Advances FDA-Cleared Cardiovascular Intelligence PlatformWHITE PLAINS, N.Y., July...
Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.
Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraineDysport is...
Linus Health AAIC Studies Advance Alzheimer’s Care: Earlier Detection, More Confident Diagnosis, and Patient-Centered Measurement
BOSTON, July 8, 2026 /PRNewswire/ -- Linus Health, an AI-driven brain health company focused on early detection and proactive intervention,...
MEGIN Launches Side-by-Side Dual-MEG Hyperscanning Facility at Tsinghua University
Two whole-head MEG systems sit side by side, giving researchers a real-time window into how two brains interact during natural...
Alpha Genesis Adds Rodent Studies, Creating an Integrated Rodent-to-Primate Preclinical Platform
New capability lets sponsors run programs from early rodent proof-of-concept through advanced nonhuman-primate translational studies with a single AAALAC-accredited, USDA-licensed...
Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
Former White House Council of Economic Advisors Brings Extensive Government, Academic, and Private Sector Experience to Advance Company's Strategic Growth...
Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions
Agreement expands Active Motif's research genomics portfolio while supporting Arima's strategic focus on its clinical diagnostics platform CARLSBAD, Calif., July...
Cumulus Neuroscience and Muse by Interaxon Bring Validated At-Home Sleep EEG to CNS Clinical Trials
Collaboration adds brain-based sleep measurement to the NeuLogiq® multi-modal platformBELFAST, Northern Ireland, DUBLIN and TORONTO, July 6, 2026 /PRNewswire/ -- Cumulus...
Neurophet Supplies ‘Neurophet AQUA’ to Raffles Medical in Singapore
Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical referenceSEOUL, South Korea, July 2,...
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
First gene replacement therapy in the EU for broad population with SMA, including children two years and older, teens and...
Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopa™, Effect on Structural Connectivity in the Brain of Parkinson’s Patients Associated with Improved Clinical Outcome
New npj Parkinson's Disease publication, building on the previously reported Hybridopa™ Phase IIa results, demonstrates for the first time, that...
Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI
NEWARK, Del., June 30, 2026 /PRNewswire/ -- The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is...
FHIMA Celebrates 50th Annual Convention with “Reach for the Stars” Theme, Nationally Recognized Keynote Speakers, and Interactive Healthcare Innovations
Florida's premier health information management conference welcomes hundreds of healthcare professionals to Orlando, July 12–15, 2026.ORLANDO, Fla., June 30, 2026...
How Advocacy Perspectives Can Improve Neurology Research, Upcoming Webinar Hosted by Xtalks
In this free webinar brought to you by Xtalks Life Sciences United (XLSU), see how advocacy perspectives can help shape...
Allucent Launches IGNITE™ Site Network to Enhance Speed, Quality, and Predictability Across Clinical Trial Delivery
Pre-qualified global site network aligned to Allucent's therapeutic Centers of Expertise (ACEs)Defined execution commitments for feasibility, startup, and enrollmentBuilt on...